Novel treatment combining antiviral and neutralizing antibody-based therapies with monitoring of spike-specific antibody and viral load for immunocompromised patients with persistent COVID-19 infection

Because prolonged viral replication of SARS-CoV-2 is increasingly being recognized among immunocompromised patients, subacute or chronic COVID-19 pneumonia can cause persistent lung damage and may lead to viral escape phenomena. Highly efficacious antiviral therapies in immunosuppressed hosts with C...

Descripción completa

Detalles Bibliográficos
Autores principales: Wada, Daiki, Nakamori, Yasushi, Maruyama, Shuhei, Shimazu, Haruka, Saito, Fukuki, Yoshiya, Kazuhisa, Kuwagata, Yasuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462070/
https://www.ncbi.nlm.nih.gov/pubmed/36085172
http://dx.doi.org/10.1186/s40164-022-00307-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462070/
https://www.ncbi.nlm.nih.gov/pubmed/36085172
http://dx.doi.org/10.1186/s40164-022-00307-9

Ejemplares similares